CONTEXT: Early age at menarche has been linked to an elevated risk of type 2 diabetes. However, the underlying mechanism is unclear. OBJECTIVE: Our objective was to examine associations between age at menarche and type 2 diabetes risk factors. DESIGN, PARTICIPANTS, AND SETTING: The BioCycle Study followed 253 healthy premenopausal women from the general population (Buffalo, NY) for one to two menstrual cycles. MAIN OUTCOME MEASURES: Age at menarche was self-reported. Body mass index and waist circumference were measured by trained personnel. Total body and trunk fat were measured by dual-energy x-ray absorptiometry. Fasting glucose, insulin, highly sensitive C-reactive protein, and SHBG levels were measured up to eight times per cycle. Insulin resistance (IR) and β-cell function were evaluated using the homeostasis model assessment (HOMA)-IR and HOMA-β. RESULTS: The mean age at menarche was 12.5 ± 1.2 yr. After adjustment for age, race, education, and physical activity, early menarche (≤12 yr) was significantly associated with an increase of 1.35 kg/m(2) in body mass index (P = 0.01), 2.52% in percent total body fat (P = 0.004), 3.02% in percent trunk fat (P = 0.004), 0.15 μIU/ml in (log)insulin (P = 0.02), 0.15 U in (log)HOMA-IR (P = 0.03), and 0.16 U in (log)HOMA-β (P = 0.01) compared with average menarche (12-14 yr). No associations were found for SHBG or highly sensitive C-reactive protein. CONCLUSIONS: Early onset of menarche is associated with unfavorable metabolic phenotypes compared with average onset of menarche in healthy premenopausal women, including reduced insulin sensitivity and β-cell function and greater total and trunk fat.
CONTEXT: Early age at menarche has been linked to an elevated risk of type 2 diabetes. However, the underlying mechanism is unclear. OBJECTIVE: Our objective was to examine associations between age at menarche and type 2 diabetes risk factors. DESIGN, PARTICIPANTS, AND SETTING: The BioCycle Study followed 253 healthy premenopausal women from the general population (Buffalo, NY) for one to two menstrual cycles. MAIN OUTCOME MEASURES: Age at menarche was self-reported. Body mass index and waist circumference were measured by trained personnel. Total body and trunk fat were measured by dual-energy x-ray absorptiometry. Fasting glucose, insulin, highly sensitive C-reactive protein, and SHBG levels were measured up to eight times per cycle. Insulin resistance (IR) and β-cell function were evaluated using the homeostasis model assessment (HOMA)-IR and HOMA-β. RESULTS: The mean age at menarche was 12.5 ± 1.2 yr. After adjustment for age, race, education, and physical activity, early menarche (≤12 yr) was significantly associated with an increase of 1.35 kg/m(2) in body mass index (P = 0.01), 2.52% in percent total body fat (P = 0.004), 3.02% in percent trunk fat (P = 0.004), 0.15 μIU/ml in (log)insulin (P = 0.02), 0.15 U in (log)HOMA-IR (P = 0.03), and 0.16 U in (log)HOMA-β (P = 0.01) compared with average menarche (12-14 yr). No associations were found for SHBG or highly sensitive C-reactive protein. CONCLUSIONS: Early onset of menarche is associated with unfavorable metabolic phenotypes compared with average onset of menarche in healthy premenopausal women, including reduced insulin sensitivity and β-cell function and greater total and trunk fat.
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Karen E Remsberg; Ellen W Demerath; Christine M Schubert; Wm Cameron Chumlea; Shumei S Sun; Roger M Siervogel Journal: J Clin Endocrinol Metab Date: 2005-02-22 Impact factor: 5.958
Authors: Michelle Heys; C Mary Schooling; Chaoqiang Jiang; Benjamin J Cowling; Xiangqian Lao; Weisen Zhang; Kar Keung Cheng; Peymane Adab; G Neil Thomas; Tai Hing Lam; Gabriel M Leung Journal: Epidemiology Date: 2007-11 Impact factor: 4.822
Authors: Subbulaxmi Trikudanathan; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Ellen W Seely; Joanne M Murabito; Caroline S Fox Journal: J Clin Endocrinol Metab Date: 2012-10-23 Impact factor: 5.958
Authors: Yasmin V Barrios; Sixto E Sanchez; Christina Nicolaidis; Pedro J Garcia; Bizu Gelaye; Qiuyue Zhong; Michelle A Williams Journal: J Adolesc Health Date: 2015-02 Impact factor: 5.012
Authors: D Stöckl; A Döring; A Peters; B Thorand; M Heier; C Huth; H Stöckl; W Rathmann; B Kowall; C Meisinger Journal: Diabetologia Date: 2011-12-15 Impact factor: 10.122
Authors: Jorge E Chavarro; Deborah J Watkins; Myriam C Afeiche; Zhenzhen Zhang; Brisa N Sánchez; David Cantonwine; Adriana Mercado-García; Clara Blank-Goldenberg; John D Meeker; Martha María Téllez-Rojo; Karen E Peterson Journal: J Pediatr Date: 2017-04-21 Impact factor: 4.406
Authors: Kristen A Johnson; Lindsey A Sjaarda; Sunni L Mumford; Rebecca A Garbose; Karen C Schliep; Donald Mattison; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman Journal: Pharmacoepidemiol Drug Saf Date: 2016-03-08 Impact factor: 2.890